Sei Investments Co. Buys 119,052 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Sei Investments Co. lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 26.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 573,635 shares of the company's stock after buying an additional 119,052 shares during the quarter. Sei Investments Co. owned about 0.48% of Privia Health Group worth $11,215,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in PRVA. Intech Investment Management LLC bought a new position in Privia Health Group during the third quarter worth $462,000. Charles Schwab Investment Management Inc. grew its position in Privia Health Group by 6.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company's stock worth $19,380,000 after buying an additional 65,152 shares in the last quarter. FMR LLC raised its stake in Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company's stock valued at $330,858,000 after purchasing an additional 271,645 shares in the last quarter. Quantbot Technologies LP raised its stake in Privia Health Group by 82.6% in the third quarter. Quantbot Technologies LP now owns 37,375 shares of the company's stock valued at $681,000 after purchasing an additional 16,904 shares in the last quarter. Finally, Benjamin Edwards Inc. increased its holdings in Privia Health Group by 360.7% in the 3rd quarter. Benjamin Edwards Inc. now owns 14,366 shares of the company's stock valued at $262,000 after buying an additional 11,248 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Transactions at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 14.20% of the company's stock.

Privia Health Group Stock Performance

Shares of Privia Health Group stock traded down $0.12 during midday trading on Thursday, hitting $22.24. The company had a trading volume of 1,353,822 shares, compared to its average volume of 774,201. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The stock has a market capitalization of $2.68 billion, a P/E ratio of 222.42, a P/E/G ratio of 3.47 and a beta of 0.85. The company has a 50 day moving average of $23.79 and a 200 day moving average of $21.27.

Analysts Set New Price Targets

PRVA has been the subject of several research analyst reports. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research report on Friday, February 28th. Canaccord Genuity Group boosted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. Needham & Company LLC restated a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Friday, March 21st. Macquarie assumed coverage on Privia Health Group in a report on Monday, December 16th. They set an "outperform" rating and a $25.00 price target on the stock. Finally, Stephens reaffirmed an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group has an average rating of "Buy" and a consensus price target of $26.67.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.